KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹25 Cr | ₹-2.39 Cr | ₹-1.91 Cr | ₹-1.24 Cr | ₹-0.90 Cr |
What is the latest Total Non-Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹-2.39 Cr |
| Mar2023 | ₹-1.91 Cr |
| Mar2022 | ₹-1.24 Cr |
| Mar2021 | ₹-0.90 Cr |
How is Total Non-Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | Positive | |
| Mar2024 | ₹-2.39 Cr | Negative | |
| Mar2023 | ₹-1.91 Cr | Negative | |
| Mar2022 | ₹-1.24 Cr | Negative | |
| Mar2021 | ₹-0.90 Cr | - | |
Compare Total Non-Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹454.7 Cr | -3.6% | -20.9% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -3.6% |
-20.9% |
-26.5% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses